HRP20151320T1 - Kompozicija päśelinjeg meda i l-alanil-l-glutamina - Google Patents
Kompozicija päśelinjeg meda i l-alanil-l-glutamina Download PDFInfo
- Publication number
- HRP20151320T1 HRP20151320T1 HRP20151320TT HRP20151320T HRP20151320T1 HR P20151320 T1 HRP20151320 T1 HR P20151320T1 HR P20151320T T HRP20151320T T HR P20151320TT HR P20151320 T HRP20151320 T HR P20151320T HR P20151320 T1 HRP20151320 T1 HR P20151320T1
- Authority
- HR
- Croatia
- Prior art keywords
- composition
- alanyl
- glutamine
- combined product
- honey
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 16
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 title claims 10
- 229960002648 alanylglutamine Drugs 0.000 title claims 10
- 235000012907 honey Nutrition 0.000 title claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 238000002560 therapeutic procedure Methods 0.000 claims 4
- 239000000969 carrier Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 1
- 206010022437 insomnia Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Claims (15)
1. Kompozicija koja se sastoji od meda i L-alanil-L-glutamina.
2. Kompozicija u skladu sa zahtjevom 1, naznačena time što je sadržaj L-alanil-L-glutamina u kompoziciji 10 težinskih % ili manje.
3. Kompozicija u skladu sa prethodnim zahtjevima, koja se sastoji od meda i L-alanil-L-glutamina.
4. Kompozicija u skladu sa bilo kojim od prethodnih zahtjeva 1 ili 2, koja se sastoji od meda, L-alanil-L-glutamina i jednog ili više farmaceutski prihvatljivih razblaživača, pomoćnih sredstava ili nosača.
5. Farmaceutska kompozicija koji sadrži kompoziciju u skladu sa bilo kojim od zahtjeva 1 ili 2, i jedan ili više farmaceutski prihvatljivih razblaživača, pomoćnih sredstava ili nosača.
6. Kombinirani proizvod koji sadrži med i L-alanil-L-glutamin, za istovremenu, odvojenu ili sekvencijalnu primjenu u terapiji.
7. Kombinirani proizvod za primjenu u skladu sa zahtjevom 6, naznačen time što 10 % ili manje ukupne težine meda i L-alanil-L-glutamina, čini L-alanil-L-glutamin.
8. Kombinirani proizvod za primjenu u skladu sa zahtjevom 6 ili zahtjevom 7, koji sadrži med i L-alanil-L-glutamin.
9. Kombinirani proizvod za primjenu u skladu sa bilo kojim od zahtjeva 6 do 8, naznačen time što su med i L-alanil-L-glutamin pripremljeni u vidu jedinstvene kompozicije.
10. Kompozicija u skladu sa bilo kojim od zahtjeva 1 do 4, farmaceutska kompozicija u skladu sa zahtjevom 5 ili kombinirani proizvod u skladu sa bilo kojim od zahtjeva 6 do 9, za primjenu u terapiji nesanice.
11. Kompozicija u skladu sa bilo kojim od zahtjeva 1 do 4, farmaceutska kompozicija u skladu sa zahtjevom 5 ili kombinirani proizvod u skladu sa bilo kojim od zahtjeva 6 do 9, za primjenu u terapiji apneje za vrijeme spavanja.
12. Kompozicija, farmaceutska kompozicija, ili kombinirani proizvod za primjenu u skladu sa zahtjevom 10, naznačeno time što se tretman sastoji od primjene kompozicije ili kombiniranog proizvoda subjektima pod terapijom, u razdoblju od 30 minuta prije spavanja.
13. Kompozicija, farmaceutska kompozicija ili kombinirani proizvod za primjenu u skladu sa zahtjevom 11, naznačeni time što se tretman sastoji od primjene kombiniranog proizvoda ili kompozicije kod subjekta koji se tretira, u razdoblju od 30 minuta prije spavanja.
14. Ne-terapeutski tretman u cilju poboljšanja spavanja, naznačen time što postupak obuhvaća primjenu kompozicije u skladu sa zahtjevima 1 do 4, farmaceutske kompozicije u skladu sa zahtjevom 5 ili kombiniranog proizvoda, u skladu sa bilo kojim od zahtjeva 6 do 9.
15. Postupak u skladu sa zahtjevom 14, koji dodatno obuhvaća korak primjene kompozicije, farmaceutske kompozicije ili kombiniranog proizvoda subjektu pod tretmanom, 30 minuta prije odlaska na spavanje.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1108343.3A GB201108343D0 (en) | 2011-05-18 | 2011-05-18 | Honey composition |
| EP12723520.8A EP2709638B1 (en) | 2011-05-18 | 2012-05-16 | Honey composition with l-alanyl-l-glutamine |
| PCT/GB2012/051090 WO2012156731A1 (en) | 2011-05-18 | 2012-05-16 | Honey composition with l-alanyl- l- glutamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20151320T1 true HRP20151320T1 (hr) | 2016-01-15 |
Family
ID=44260736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20151320TT HRP20151320T1 (hr) | 2011-05-18 | 2015-12-03 | Kompozicija päśelinjeg meda i l-alanil-l-glutamina |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US10314879B2 (hr) |
| EP (1) | EP2709638B1 (hr) |
| JP (2) | JP6328552B2 (hr) |
| KR (1) | KR101900904B1 (hr) |
| CN (2) | CN103747791B (hr) |
| AU (1) | AU2012257566B2 (hr) |
| CA (1) | CA2834182C (hr) |
| CY (1) | CY1117053T1 (hr) |
| DK (1) | DK2709638T3 (hr) |
| ES (1) | ES2553655T3 (hr) |
| GB (1) | GB201108343D0 (hr) |
| HK (1) | HK1196097A1 (hr) |
| HR (1) | HRP20151320T1 (hr) |
| HU (1) | HUE028293T2 (hr) |
| MX (1) | MX337139B (hr) |
| PL (1) | PL2709638T3 (hr) |
| PT (1) | PT2709638E (hr) |
| RS (1) | RS54412B1 (hr) |
| SI (1) | SI2709638T1 (hr) |
| SM (1) | SMT201600056B (hr) |
| WO (1) | WO2012156731A1 (hr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201108343D0 (en) * | 2011-05-18 | 2011-06-29 | Hibernation Honey Ltd | Honey composition |
| EP3490971A4 (en) * | 2016-08-01 | 2020-02-26 | Filament Biosolutions Inc. | METHOD FOR TREATING AND PREVENTING SIDE EFFECTS OF A CANCER TREATMENT |
| KR102183558B1 (ko) * | 2016-12-30 | 2020-11-26 | 이노바이오 코오포레이션 리미티드 | L-알라닐-l-글루타민 생합성 효소를 코딩하는 유전자 및 그 용도 |
| CN113040393A (zh) * | 2021-03-31 | 2021-06-29 | 杨继辉 | 一种干预焦虑睡眠障碍的营养配方 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2919059A1 (de) * | 1979-05-10 | 1980-11-20 | Josef Dipl Chem Dr Rer N Klosa | Diaetetisches mittel und verfahren zu seiner herstellung |
| US4532143A (en) * | 1984-06-15 | 1985-07-30 | The J. M. Smucker Company | Spreadable honey |
| US4973491A (en) * | 1989-06-06 | 1990-11-27 | Ontario Ministry Of Agriculture And Food | Honey product |
| JP2829793B2 (ja) | 1991-01-10 | 1998-12-02 | 長谷川香料株式会社 | 飲食品の蜂蜜様風味改善方法 |
| GB9121467D0 (en) | 1991-10-10 | 1991-11-27 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| JP3473976B2 (ja) * | 1992-10-29 | 2003-12-08 | 協和醗酵工業株式会社 | アラニルグルタミンの製造法 |
| JP4664071B2 (ja) | 2002-08-01 | 2011-04-06 | エーザイ コーポレーション オブ ノース アメリカ | グルタミンによるガンの改良治療 |
| JP4595651B2 (ja) * | 2005-04-25 | 2010-12-08 | 株式会社デンソー | 生体センサ、睡眠情報処理方法、及び睡眠情報処理装置 |
| CN101287458A (zh) * | 2005-10-12 | 2008-10-15 | 株式会社大塚制药工场 | 低血糖症状抑制用组合物 |
| CN101312660B (zh) * | 2005-11-23 | 2013-07-17 | 可口可乐公司 | 供体重管理之高效甜味剂以及经彼甜化的组成物 |
| JP5138581B2 (ja) * | 2006-03-23 | 2013-02-06 | 協和発酵バイオ株式会社 | 筋肉疲労改善剤 |
| WO2007119503A1 (ja) * | 2006-03-23 | 2007-10-25 | Kyowa Hakko Kogyo Co., Ltd. | 寝起き改善剤 |
| JP5046364B2 (ja) * | 2006-09-15 | 2012-10-10 | パナソニック株式会社 | 睡眠状況評価システム及びそのプログラム |
| CN101041008A (zh) * | 2007-04-28 | 2007-09-26 | 王军 | 三冬丹 |
| EP2177113A1 (en) | 2008-10-15 | 2010-04-21 | Nestec S.A. | Improved liver glycocen synthesis |
| JP2010260853A (ja) * | 2009-04-08 | 2010-11-18 | Kyowa Hakko Bio Co Ltd | アラニルグルタミンを含有する造粒粉末、顆粒または錠剤 |
| CN101999572A (zh) | 2010-11-08 | 2011-04-06 | 王福起 | 助眠蜜及制备方法 |
| GB201108343D0 (en) * | 2011-05-18 | 2011-06-29 | Hibernation Honey Ltd | Honey composition |
-
2011
- 2011-05-18 GB GBGB1108343.3A patent/GB201108343D0/en not_active Ceased
-
2012
- 2012-05-16 CA CA2834182A patent/CA2834182C/en active Active
- 2012-05-16 PL PL12723520T patent/PL2709638T3/pl unknown
- 2012-05-16 SI SI201230398T patent/SI2709638T1/sl unknown
- 2012-05-16 DK DK12723520.8T patent/DK2709638T3/da active
- 2012-05-16 RS RS20150811A patent/RS54412B1/en unknown
- 2012-05-16 MX MX2013012967A patent/MX337139B/es active IP Right Grant
- 2012-05-16 ES ES12723520.8T patent/ES2553655T3/es active Active
- 2012-05-16 PT PT127235208T patent/PT2709638E/pt unknown
- 2012-05-16 KR KR1020137032788A patent/KR101900904B1/ko active IP Right Grant
- 2012-05-16 CN CN201280023801.9A patent/CN103747791B/zh active Active
- 2012-05-16 WO PCT/GB2012/051090 patent/WO2012156731A1/en active Application Filing
- 2012-05-16 US US14/114,649 patent/US10314879B2/en active Active
- 2012-05-16 JP JP2014510877A patent/JP6328552B2/ja active Active
- 2012-05-16 EP EP12723520.8A patent/EP2709638B1/en active Active
- 2012-05-16 AU AU2012257566A patent/AU2012257566B2/en active Active
- 2012-05-16 HU HUE12723520A patent/HUE028293T2/en unknown
- 2012-05-16 CN CN201810011129.0A patent/CN108159391A/zh active Pending
-
2014
- 2014-09-24 HK HK14109598.1A patent/HK1196097A1/xx unknown
-
2015
- 2015-12-03 HR HRP20151320TT patent/HRP20151320T1/hr unknown
- 2015-12-17 CY CY20151101156T patent/CY1117053T1/el unknown
-
2016
- 2016-02-24 SM SM201600056T patent/SMT201600056B/xx unknown
- 2016-10-27 JP JP2016210960A patent/JP6336003B2/ja active Active
-
2019
- 2019-02-25 US US16/283,918 patent/US20190192612A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK2709638T3 (da) | 2015-12-21 |
| HUE028293T2 (en) | 2016-12-28 |
| US20190192612A1 (en) | 2019-06-27 |
| SMT201600056B (it) | 2016-04-29 |
| JP6328552B2 (ja) | 2018-05-23 |
| AU2012257566B2 (en) | 2017-03-02 |
| PL2709638T3 (pl) | 2016-03-31 |
| JP6336003B2 (ja) | 2018-06-06 |
| US20140186457A1 (en) | 2014-07-03 |
| CY1117053T1 (el) | 2017-04-05 |
| ES2553655T3 (es) | 2015-12-10 |
| MX2013012967A (es) | 2014-05-13 |
| GB201108343D0 (en) | 2011-06-29 |
| CN108159391A (zh) | 2018-06-15 |
| AU2012257566A1 (en) | 2013-11-14 |
| KR101900904B1 (ko) | 2018-09-21 |
| JP2014513713A (ja) | 2014-06-05 |
| WO2012156731A1 (en) | 2012-11-22 |
| EP2709638B1 (en) | 2015-09-30 |
| JP2017061488A (ja) | 2017-03-30 |
| CA2834182C (en) | 2021-05-18 |
| SI2709638T1 (sl) | 2016-01-29 |
| EP2709638A1 (en) | 2014-03-26 |
| KR20140058435A (ko) | 2014-05-14 |
| CN103747791B (zh) | 2018-01-30 |
| MX337139B (es) | 2016-02-12 |
| CA2834182A1 (en) | 2012-11-22 |
| US10314879B2 (en) | 2019-06-11 |
| HK1196097A1 (en) | 2014-12-05 |
| RS54412B1 (en) | 2016-04-28 |
| CN103747791A (zh) | 2014-04-23 |
| PT2709638E (pt) | 2016-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201800199A1 (ru) | Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и снижения веса, композиции, лекарственное стедство | |
| JP2014530220A5 (hr) | ||
| EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| HRP20151320T1 (hr) | Kompozicija päśelinjeg meda i l-alanil-l-glutamina | |
| PE20170302A1 (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington | |
| WO2016190683A8 (ko) | 길경 추출물을 함유하는 근육 질환 예방 및 치료용 또는 근 기능 개선용 조성물 | |
| NZ630367A (en) | Methods of treatment of pediatric solid tumor | |
| PH12015500653B1 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
| RU2013132566A (ru) | Терапевтическое средство от грыжи межпозвоночного диска | |
| AR091724A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fampridina, composicion farmaceutica | |
| EA201690997A1 (ru) | Композиция для применения в лечении стойкого кашля | |
| SA113340494B1 (ar) | تركيبة لعلاج اضطرابات أيضية | |
| EP2575456A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ECCHYMOSIS | |
| FI2683245T4 (fi) | Menetelmiä ja koostumuksia masennuksen hoitamiseen syklobentsapriiniä käyttämällä | |
| JP2017061488A5 (hr) | ||
| UA112981C2 (uk) | Варіант людського gdnf | |
| DE502009000459D1 (de) | Lektinzusammensetzung zur Prophylaxe und/oder Behandlung von unerwünschten Arzneimittelnebenwirkungen | |
| MX2015014939A (es) | Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias e hipertension. | |
| MX2013008713A (es) | Metodos para tratar taquicarida y/o controlar la frecuencia cardiaca, minimizando y/o controlando al mismo tiempo la hipotesis. | |
| CN103784910A (zh) | 一种治疗高血压的足浴药 | |
| CN105582126A (zh) | 一种治疗口腔溃疡的药物 | |
| RU2013154562A (ru) | Способы и композиции для сохранения безжировой массы тела в процессе похудения | |
| CN104187895A (zh) | 一种百合苦瓜汤及其制作方法 | |
| EA201592261A1 (ru) | Фармацевтические композиции, включающие агомелатин в форме сокристаллов агомелатина с органической кислотой |